Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Mosquitoes Are a Choice

In the United States, mosquito-borne diseases like malaria, yellow fever, and dengue fever have resurfaced in recent years, despite having been eradicated in the past. This resurgence is attributed to increasing temperatures, which create favorable conditions for mosquitoes, and the development of mosquito resistance to pesticides.

For instance, in 2024, the U.S. reported nearly 4,000 cases of dengue, a dramatic 360% increase compared to the average of 830 cases per year over the previous decade. Florida, California, and Texas all experienced locally-acquired transmissions of dengue, while Puerto Rico declared a public health emergency due to the disease.

Malaria also saw a return – ten locally-acquired cases were reported in the U.S. in 2023, the first in two decades. Although yellow fever remains absent, the mosquitoes capable of spreading it are still present. However, experts believe that these threats can be mitigated effectively without causing significant environmental harm.

According to the information available, the U.S. has the necessary resources and mosquito population to eliminate these diseases entirely within its borders. The delay in implementing this strategy is due to the genetic engineering technology being caught up in regulatory limbo.

Genetic engineering offers a solution to this problem. Researchers can insert a gene into male mosquitoes, causing their offspring to die before reaching adulthood. This technique was successfully demonstrated in fruit flies in 2000. Oxitec, a company formed to work with governments in researching and deploying this technology, has engineered the same gene into male Aedes aegypti, the mosquito species that spreads dengue and yellow fever.

This engineered male mosquito kills only female offspring, while the males survive and pass the gene on for several generations, driving down mosquito numbers without requiring constant replenishment of engineered males. Moreover, the gene eventually declines in the wild, making the technique self-limiting and efficient.

The effectiveness of this technique was demonstrated in the Cayman Islands, where sustained releases reduced the Aedes aegypti population by 80%, and in Juazeiro, Brazil, where it reduced the population by about 95%. Oxitec submitted its data for approval in the U.S. in 2010, but the process has been slow. The USDA had previously used a technique called 'sterile insect technique', which sterilized male insects with radiation and released them into the wild to mate with wild females, resulting in no offspring.

This method successfully controlled the screwworm pest in the 1960s. However, the recent case in Texas, indicating the return of screwworm after 60 years, suggests that the U.S. still needs this approach.

The agency that initially managed mass insect releases – the USDA – rejected Oxitec's application for approval, directing them to apply to the Food and Drug Administration (FDA) instead. The FDA eventually realized that the gene-edited mosquitoes were not properly classified under their existing regulations, which treated altered genomic DNA in animals as drugs due to the potential impact on the animal's body.

The delay in approval has hindered the implementation of this promising technology, leaving the U.S. vulnerable to the resurgence of mosquito-borne diseases.

Written by urgent.news from Hacker News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at worksinprogress.co →

More in Health & Medicine

More from Sunday 4 October →